Clinical trial
REsearching Covid-19 Outcomes in Diabetes (RECODE)
NCT04805970 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REsearching Covid-19 Outcomes in Diabetes (RECODE)
- Lead sponsor
- AdventHealth Translational Research Institute
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 24, 2021
- Completion date
- December 31, 2026
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, diabetes